Hainan Huluwa Pharmaceutical Group Co Ltd

Huluwa Pharmaceutical Group takes "Healthy Chinese Baby" as its corporate mission, escorts the healthy growth of Chinese children, and is committed to becoming the "First Brand of Pediatric Medicine in China".

Huluwa Pharmaceutical Group is a group enterprise headquartered in Haikou. It was reorganized in 2008 and listed on the main board of the Shanghai Stock Exchange in July 2020 (stock abbreviation: Huluwa, stock code: 605199). It is the announcement of the overall plan for the construction of Hainan Free Trade Port. The first listed company in Hainan. After more than ten years of hard work, the group has made intensive efforts in the field of pediatric medicine, and has now developed into one of the leading companies in the field of professional pediatric pharmaceuticals.

Huluwa Pharmaceutical Group focuses on R&D innovation, lean production, and marketing reform. It has built 6 intelligent manufacturing bases including Haikou Medicine Valley Production Base, Haikou Bonded Production Base, Guangxi Nanning Production Base, and Guangxi Laibin Traditional Chinese Medicine Extraction Base. The intelligent manufacturing base for children's medicines is under construction, with 46 advanced production lines; a total of 34 types of children's medicines are being produced and sold (all with clear dosage for children). There are about 110 products under research and development; the sales network covers more than 2,000 counties and cities in all provinces in China.